WCRX Share Price

Open 22.85 Change Price %
High 23.05 1 Day -0.18 -0.78
Low 22.71 1 Week 0.00 0.00
Close 22.93 1 Month 0.00 0.00
Volume 24388044 1 Year 0.00 0.00
52 Week High 67.55
52 Week Low 45.46
WCRX Important Levels
Resistance 2 23.25
Resistance 1 23.12
Pivot 22.90
Support 1 22.74
Support 2 22.61
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Warner Chilcott plc (NASDAQ: WCRX)

WCRX Technical Analysis 5
As on 30th Sep 2013 WCRX Share Price closed @ 22.93 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 16.09 & Strong Buy for SHORT-TERM with Stoploss of 21.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
WCRX Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
WCRX Other Details
Segment EQ
Market Capital 2842975232.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
WCRX Address
WCRX
N/A
WCRX Latest News
Interactive Technical Analysis Chart Warner Chilcott plc ( WCRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Warner Chilcott plc
WCRX Business Profile
Warner Chilcott Public Limited Company is a specialty pharmaceutical company. The Company is focused on the women�s healthcare, gastroenterology, dermatology and urology segments of the branded pharmaceuticals market, primarily in North America. The Company�s hormonal contraceptive product offerings include LOESTRIN 24 FE (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), the branded product in the United States hormonal contraception market, and LO LOESTRIN FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), its new oral contraceptive product, launched in January 2011, that offers women the lowest dosage of estrogen of any oral contraceptive available in the United States market. In October 2013, Actavis Inc acquired the entire share capital of Warner Chilcott PLC.